Adaptimmune Therapeutics Plc Margen operativo

¿Qué es el Margen operativo de Adaptimmune Therapeutics Plc?

El Margen operativo de Adaptimmune Therapeutics Plc es -54.47%

¿Cuál es la definición de Margen operativo?



El margen operativo es la proporción del ingreso operativo dividido por las ventas netas y presentado en porcentaje.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Margen operativo de compañías en Sector Health Care en NASDAQ en comparadas con Adaptimmune Therapeutics Plc

¿Qué hace Adaptimmune Therapeutics Plc?

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

Empresas con margen operativo similar a Adaptimmune Therapeutics Plc